Posted: Apr 2, 2020 / 03:09 PM UTC/ Updated: Apr 2, 2020 / 03:09 PM UTC
From Vireo Health of New York:
The following statement can be attributed to Ari Hoffnung, CEO of Vireo Health of New York, one of only 10 registered organizations licensed to grow, manufacture and sell medical cannabis in New York:
“While we are disappointed by reports that adult-use marijuana legislation will not be included in this year’s budget, it is certainly understandable given the extraordinary challenges our state is facing combatting the Coronavirus. We remain confident that legalization would not only help end the decades-long War on Drugs but also address the budgetary aftermath of the Coronavirus pandemic.
“We look forward to reengaging on this important policy issue at the appropriate time and continuing to work with the Department of Health to make medical marijuana more affordable and accessible to New Yorkers struggling to make ends meet in the midst of an unprecedented economic crisis.
“In the meantime, we remain deeply grateful to our physician-led team of more than 400 employees in New York and beyond — including cultivators, pharmacists, security guards, and delivery drivers — for leaving their families each morning and continuing to put the medical needs of their patients first.”
Additional Information about Vireo Health’s Response to COVID-19 Pandemic:
As one of 10 registered organizations licensed to grow, manufacture and sell medical cannabis, Vireo Health has been deemed an ‘essential business’ by the New York State Department of Health, Vireo Health is working hard to safely serve hundreds of medical marijuana patients each day by offering: In order to protect patients and employees, Vireo Health has implemented a variety of enhanced measures, including additional cleaning and sanitation policies, new standard operating procedures, and workplace and